Jasmine Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jasmine Hwang has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Heather Wachtel
Department of Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania
4 shared publications James Sharpe
Department of Surgery, Center for Surgery and Health Economics University of Pennsylvania Philadelphia Pennsylvania USA
4 shared publicationsRachel R. Kelz
Department of Surgery University of Pennsylvania Philadelphia Pennsylvania USA
4 shared publications- Amanda Bader
Department of Surgery, University of Pennsylvania Health System, Philadelphia
3 shared publications - Jesse E. Passman
Department of Surgery University of Pennsylvania Philadelphia Pennsylvania USA
3 shared publications Douglas Fraker
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
2 shared publications
Latest Publications
- 21 July 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (5) , 710-719
Impact of Serious Mental Illness and Dementia‐Related Disorders on Post‐Parathyroidectomy Healthcare Utilization and Cost
Background and Objectives: Serious mental illness and dementia‐related disorders are associated with worse postoperative outcomes. We evaluated the impact of pre‐existing neuropsychiatric disorders on post‐parathyroidectomy healthcare utilization. Methods: Adult patients who underwent parathyroidectomy for primary hyperparathyroidism were identified in the Healthcare Cost and Utilization Project State Inpatient and Ambulatory Surgery Databases (2016–2021). Neuropsychiatric disorders were classified. The primary outcome was 30‐day readmission. Secondary outcomes were length of stay and costs (2021USD). Balancing weights were used for covariate adjustment. Subgroup analyses were performed in serious mental illness and dementia‐related disorder groups. Results: Of 10,733 parathyroidectomy patients, 1,249 (11.6%) had neuropsychiatric disorders: 60.5% mood, 58.8% anxiety, 5.1% dementia‐related, and 1.8% schizophrenia‐type disorders. Patients with neuropsychiatric disorders were younger and more likely to undergo emergent/urgent parathyroidectomy ( p < 0.001). There was no difference in adjusted odds of readmission between patients with and without neuropsychiatric disorders (0.91[95%CI 0.55, 1.49], p = 0.710). Adjusted length of stay was 0.20 days longer among patients with neuropsychiatric disorders ([95%CI: + 0.11, + 0.30]; p < 0.001). Adjusted encounter costs were similar between groups (median[IQI]: neuropsychiatric disorder $6767[5290,8589] vs. no neuropsychiatric disorder $6511[5259, 8550]; p = 0.080). Subgroup analyses showed similar results. Conclusions: Patients with neuropsychiatric disorders have similar parathyroidectomy readmission and cost. They have slightly longer length of stay that may ameliorate the risk of readmission.
- 21 July 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (5) , 710-719
Impact of Serious Mental Illness and Dementia‐Related Disorders on Post‐Parathyroidectomy Healthcare Utilization and Cost
Background and Objectives: Serious mental illness and dementia‐related disorders are associated with worse postoperative outcomes. We evaluated the impact of pre‐existing neuropsychiatric disorders on post‐parathyroidectomy healthcare utilization. Methods: Adult patients who underwent parathyroidectomy for primary hyperparathyroidism were identified in the Healthcare Cost and Utilization Project State Inpatient and Ambulatory Surgery Databases (2016–2021). Neuropsychiatric disorders were classified. The primary outcome was 30‐day readmission. Secondary outcomes were length of stay and costs (2021USD). Balancing weights were used for covariate adjustment. Subgroup analyses were performed in serious mental illness and dementia‐related disorder groups. Results: Of 10,733 parathyroidectomy patients, 1,249 (11.6%) had neuropsychiatric disorders: 60.5% mood, 58.8% anxiety, 5.1% dementia‐related, and 1.8% schizophrenia‐type disorders. Patients with neuropsychiatric disorders were younger and more likely to undergo emergent/urgent parathyroidectomy ( p < 0.001). There was no difference in adjusted odds of readmission between patients with and without neuropsychiatric disorders (0.91[95%CI 0.55, 1.49], p = 0.710). Adjusted length of stay was 0.20 days longer among patients with neuropsychiatric disorders ([95%CI: + 0.11, + 0.30]; p < 0.001). Adjusted encounter costs were similar between groups (median[IQI]: neuropsychiatric disorder $6767[5290,8589] vs. no neuropsychiatric disorder $6511[5259, 8550]; p = 0.080). Subgroup analyses showed similar results. Conclusions: Patients with neuropsychiatric disorders have similar parathyroidectomy readmission and cost. They have slightly longer length of stay that may ameliorate the risk of readmission.
- 28 May 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 260, 117069
Innocent until proven guilty … by documentation
- 28 May 2026
- Published by Elsevier in The American Journal of Surgery
- Vol. 260, 117069
Innocent until proven guilty … by documentation
- Open Access
- 7 April 2026
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 13
Healthcare Professionals’ Attitudes and Perspectives on Diversity, Equity and Inclusion in an Academic Culture: A Freelisting Study
Objectives: Successful implementation of diversity, equity, and inclusion (DEI) initiatives requires understanding the perspectives of diverse student populations. This study explored how graduate health and public health professionals perceive DEI and their implementation barriers and facilitators. Methods: This qualitative freelisting study was conducted from June to August 2024 at a single urban academic institution in Pennsylvania. Eligible participants were current or recent graduate students in health or public health programs. Participants engaged in structured freelisting exercises, where they listed words, themes, and reflections related to 5 different DEI domains. Responses were coded by multiple researchers, and the Smith Salience Index was applied to quantify the importance of themes across participants. Results: Thirty participants completed the study. The most salient themes were “inclusivity and representation” and “diverse and receptive leadership” as essential components of DEI. Participants expressed both positive and negative experiences. White and man-identifying participants more often emphasized positive aspects, while older, woman-identifying, and participants from racial and ethnic minority backgrounds highlighted the need for institutional “commitment, accountability, and buy-in.” The most frequently cited barrier to DEI was “lack of adequate funding and resources.” Conclusion: Graduate health and public health professionals emphasized the importance of representation and leadership diversity in fostering inclusive environments. Institutional investment in DEI—particularly through recruitment, retention, leadership representation, and sustained funding—is critical to cultivating a workforce prepared to advance health equity for the communities they serve. Differences in perceptions by race, gender, and age underscore the need for tailored approaches to DEI implementation.
- 7 April 2026
- Published by SAGE Publications in Journal of Medical Education and Curricular Development
- Vol. 13
Open AccessHealthcare Professionals’ Attitudes and Perspectives on Diversity, Equity and Inclusion in an Academic Culture: A Freelisting Study
Objectives: Successful implementation of diversity, equity, and inclusion (DEI) initiatives requires understanding the perspectives of diverse student populations. This study explored how graduate health and public health professionals perceive DEI and their implementation barriers and facilitators. Methods: This qualitative freelisting study was conducted from June to August 2024 at a single urban academic institution in Pennsylvania. Eligible participants were current or recent graduate students in health or public health programs. Participants engaged in structured freelisting exercises, where they listed words, themes, and reflections related to 5 different DEI domains. Responses were coded by multiple researchers, and the Smith Salience Index was applied to quantify the importance of themes across participants. Results: Thirty participants completed the study. The most salient themes were “inclusivity and representation” and “diverse and receptive leadership” as essential components of DEI. Participants expressed both positive and negative experiences. White and man-identifying participants more often emphasized positive aspects, while older, woman-identifying, and participants from racial and ethnic minority backgrounds highlighted the need for institutional “commitment, accountability, and buy-in.” The most frequently cited barrier to DEI was “lack of adequate funding and resources.” Conclusion: Graduate health and public health professionals emphasized the importance of representation and leadership diversity in fostering inclusive environments. Institutional investment in DEI—particularly through recruitment, retention, leadership representation, and sustained funding—is critical to cultivating a workforce prepared to advance health equity for the communities they serve. Differences in perceptions by race, gender, and age underscore the need for tailored approaches to DEI implementation.
- 3 March 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (4) , 433-443
A Multi‐State Cohort Study of Hospital Utilization and Treatment Modality for Malignant Gastrointestinal Obstructions
Introduction: Malignant obstructions are associated with morbidity, mortality, and impaired quality of life with limited population‐based data on practice patterns. We characterized the association between prior cancer‐related hospitalizations and receipt of operative treatment for obstruction. Methods: We performed a retrospective cohort study of patients hospitalized with malignant gastrointestinal obstructions from colorectal, gynecologic (GYN), and hepato‐pancreatico‐biliary (HPB) cancers in 12 states using the Healthcare Cost and Utilization Project State Inpatient Database, 2016–2020. The primary exposure was the number of cancer‐related hospitalizations in the year prior to the first hospitalization for an obstruction. Risk‐adjusted use of operative treatment during the index hospitalization, enrollment in hospice, length of stay, and inpatient mortality were examined using regression. Results: Of 8665 patients, the median age was 67 years [Interquartile Range: 58,76]. There were 3789 patients with colorectal (43.7%), 2593 patients with GYN (29.9%), and 2337 patients (26.9%) with HPB cancers. The operative rate was 24.1%. Patients with prior hospitalizations were less likely to undergo operative treatment than those who were not previously hospitalized (operative rate difference: –7.8%, p < 0.001). Operative treatment was associated with longer median length of stay ( + 8.6 days, p < 0.001), lower rates of hospice enrollment (–3.0%, p = 0.002) and lower rates of inpatient mortality (operative rate difference −2.3%, p < 0.001). The time between readmissions also decreased with each recurrent obstruction in colorectal and GYN cancers. Conclusion: A greater number of previous cancer‐related hospitalizations was associated with lower rates of operative treatment during the first hospitalization for a malignant obstruction. These data provide insight into the treatment trends for patients with malignant obstructions and may be helpful when counseling patients about the natural course of their disease.
- 3 March 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (4) , 433-443
A Multi‐State Cohort Study of Hospital Utilization and Treatment Modality for Malignant Gastrointestinal Obstructions
Introduction: Malignant obstructions are associated with morbidity, mortality, and impaired quality of life with limited population‐based data on practice patterns. We characterized the association between prior cancer‐related hospitalizations and receipt of operative treatment for obstruction. Methods: We performed a retrospective cohort study of patients hospitalized with malignant gastrointestinal obstructions from colorectal, gynecologic (GYN), and hepato‐pancreatico‐biliary (HPB) cancers in 12 states using the Healthcare Cost and Utilization Project State Inpatient Database, 2016–2020. The primary exposure was the number of cancer‐related hospitalizations in the year prior to the first hospitalization for an obstruction. Risk‐adjusted use of operative treatment during the index hospitalization, enrollment in hospice, length of stay, and inpatient mortality were examined using regression. Results: Of 8665 patients, the median age was 67 years [Interquartile Range: 58,76]. There were 3789 patients with colorectal (43.7%), 2593 patients with GYN (29.9%), and 2337 patients (26.9%) with HPB cancers. The operative rate was 24.1%. Patients with prior hospitalizations were less likely to undergo operative treatment than those who were not previously hospitalized (operative rate difference: –7.8%, p < 0.001). Operative treatment was associated with longer median length of stay ( + 8.6 days, p < 0.001), lower rates of hospice enrollment (–3.0%, p = 0.002) and lower rates of inpatient mortality (operative rate difference −2.3%, p < 0.001). The time between readmissions also decreased with each recurrent obstruction in colorectal and GYN cancers. Conclusion: A greater number of previous cancer‐related hospitalizations was associated with lower rates of operative treatment during the first hospitalization for a malignant obstruction. These data provide insight into the treatment trends for patients with malignant obstructions and may be helpful when counseling patients about the natural course of their disease.
- 14 November 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (12) , 1658-1669
Readmission and Cost of Parathyroidectomy By Admission Status in Secondary Hyperparathyroidism
Key Points: Among patients with kidney failure treated with dialysis, 37% underwent parathyroidectomy in the outpatient setting. Significant differences exist between patients selected for inpatient versus outpatient parathyroidectomy. Risk-adjusted readmission rates are similar after inpatient or outpatient parathyroidectomy for secondary hyperparathyroidism. Background: Outpatient parathyroidectomy for secondary hyperparathyroidism of kidney disease is increasing. Reduced length of stay is often associated with higher rates of readmission. The safety of outpatient parathyroidectomy in this population must be evaluated given the morbidity and higher risk of post-parathyroidectomy hungry bone syndrome associated with kidney failure. In this study, we compare parathyroidectomy outcomes and costs by admission status in dialysis-dependent patients with secondary hyperparathyroidism. Methods: Adult patients on dialysis who underwent elective parathyroidectomy for secondary hyperparathyroidism were identified in the Healthcare Cost and Utilization Project State Inpatient and State Ambulatory Surgery Databases from five geographically diverse states (2013–2019). Patients were classified by admission status: inpatient and outpatient (overnight or same-day). The primary outcome was 30-day readmission. Secondary outcomes were parathyroidectomy-related complications and cost. Outcomes were compared by admission status using chi-squared tests and costs using median quantile regression. Balancing weights were used for adjustment. Forward selection with logistic regression was used to identify factors associated with readmission among outpatients. Results: Among 1267 study participants, 63% were inpatients. Among outpatients, 40% underwent overnight stay and 42% underwent same-day discharge. Inpatients were more likely to be younger, Black race, have nonprivate insurance, and increased comorbidities than outpatients ( P < 0.05). Overall readmission rate was 19%. Readmission was higher among inpatients (Inpatient: 22% versus Outpatient: 15%; P = 0.002). After balancing weights, adjusted 30-day readmission rate was similar between inpatients and outpatients (14% versus 15%; P = 0.79). Readmission was similar between overnight stay and same-day discharge (Unadjusted: 12% versus 15%; P = 0.47. Adjusted: 15% versus 15%; P = 0.97). Outpatients with parathyroid autotransplantation, anxiety disorder, autoimmune conditions, congestive heart failure, and moderate/severe liver failure had significantly increased odds of readmission after parathyroidectomy. Adjusted median costs varied significantly (Adjusted Inpatient: $9615 [Interquartile range (IQR), $6463–12,963] versus Outpatient: $6357 [IQR, $4966–8153]; P < 0.001; Adjusted Overnight: $6453 [IQR, $5551–7850] versus Same-day: $5526 [IQR, $4346–7187]; P < 0.001). Conclusions: Select patients with secondary hyperparathyroidism may undergo outpatient parathyroidectomy safely with reduced costs.
- 14 November 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (12) , 1658-1669
Readmission and Cost of Parathyroidectomy By Admission Status in Secondary Hyperparathyroidism
Key Points: Among patients with kidney failure treated with dialysis, 37% underwent parathyroidectomy in the outpatient setting. Significant differences exist between patients selected for inpatient versus outpatient parathyroidectomy. Risk-adjusted readmission rates are similar after inpatient or outpatient parathyroidectomy for secondary hyperparathyroidism. Background: Outpatient parathyroidectomy for secondary hyperparathyroidism of kidney disease is increasing. Reduced length of stay is often associated with higher rates of readmission. The safety of outpatient parathyroidectomy in this population must be evaluated given the morbidity and higher risk of post-parathyroidectomy hungry bone syndrome associated with kidney failure. In this study, we compare parathyroidectomy outcomes and costs by admission status in dialysis-dependent patients with secondary hyperparathyroidism. Methods: Adult patients on dialysis who underwent elective parathyroidectomy for secondary hyperparathyroidism were identified in the Healthcare Cost and Utilization Project State Inpatient and State Ambulatory Surgery Databases from five geographically diverse states (2013–2019). Patients were classified by admission status: inpatient and outpatient (overnight or same-day). The primary outcome was 30-day readmission. Secondary outcomes were parathyroidectomy-related complications and cost. Outcomes were compared by admission status using chi-squared tests and costs using median quantile regression. Balancing weights were used for adjustment. Forward selection with logistic regression was used to identify factors associated with readmission among outpatients. Results: Among 1267 study participants, 63% were inpatients. Among outpatients, 40% underwent overnight stay and 42% underwent same-day discharge. Inpatients were more likely to be younger, Black race, have nonprivate insurance, and increased comorbidities than outpatients ( P < 0.05). Overall readmission rate was 19%. Readmission was higher among inpatients (Inpatient: 22% versus Outpatient: 15%; P = 0.002). After balancing weights, adjusted 30-day readmission rate was similar between inpatients and outpatients (14% versus 15%; P = 0.79). Readmission was similar between overnight stay and same-day discharge (Unadjusted: 12% versus 15%; P = 0.47. Adjusted: 15% versus 15%; P = 0.97). Outpatients with parathyroid autotransplantation, anxiety disorder, autoimmune conditions, congestive heart failure, and moderate/severe liver failure had significantly increased odds of readmission after parathyroidectomy. Adjusted median costs varied significantly (Adjusted Inpatient: $9615 [Interquartile range (IQR), $6463–12,963] versus Outpatient: $6357 [IQR, $4966–8153]; P < 0.001; Adjusted Overnight: $6453 [IQR, $5551–7850] versus Same-day: $5526 [IQR, $4346–7187]; P < 0.001). Conclusions: Select patients with secondary hyperparathyroidism may undergo outpatient parathyroidectomy safely with reduced costs.
- 28 October 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 239, 116048
Demystifying delays: Factors associated with timely treatment of adrenocortical carcinoma
- 28 October 2024
- Published by Elsevier in The American Journal of Surgery
- Vol. 239, 116048
Demystifying delays: Factors associated with timely treatment of adrenocortical carcinoma